Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02147392 · ClinicalTrials.gov registry record · Early Phase 1
Assessment of [11C]ER176 to Image Translocator Protein in Brain and Whole Body of Healthy People
A Early Phase 1 study, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- Early Phase 1
- Development phase
- 16
- Enrollment target
NCT02147392 is a Early Phase 1 study that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 16 participants.
The verdict
NCT02147392, a Early Phase 1 study, has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
Background: \- A protein called translocator protein may play a role in brain inflammation. Sometimes it is present at higher levels in the lungs than in the brain. Researchers want to see if a drug called \[11C\]ER176 can provide an image of this protein in the brain. Objective: \- To test the ability of a drug to image a protein, and test how it is distributed in the body. Eligibility: \- Healthy adults over age 18. Design: * Participants will be screened with medical history, physical exam, and blood and urine tests. * Participants will have a PET scan of the brain using \[11C\]ER176. It will be injected through an intravenous tube into 1-2 arm veins. A tube may also be put into an artery at the wrist or elbow. Some participants will also have a lung scan. * For the PET, participants will lie on a bed that slides in and out of a doughnut-shaped scanner. A plastic mask will be molded to their face and head. They may be wrapped with restraining sheets. The scan will last about 120 minutes. Blood may be taken during the scan. * Blood and urine will be taken before and after the scan. * During another visit, participants will have an MRI scan of the brain. Participants will lie on a table that slides in and out of a metal cylinder. A strong magnetic field and radio waves will take pictures of the brain. The scanner makes loud knocking noises. Participants will be given earplugs. * Some participants will have only a whole-body PET scan using \[11C\]ER176.
Interventions
- DRUG [11C]ER-176
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2014-05-14 |
| Est. Completion | 2016-06-16 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02147392
The ClinicalTrials.gov registry entry for NCT02147392 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [11C]ER-176 is the first listed.
NCT02147392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02147392 about?
NCT02147392 is a clinical study titled "Assessment of [11C]ER176 to Image Translocator Protein in Brain and Whole Body of Healthy People". Background: \- A protein called translocator protein may play a role in brain inflammation. Sometimes it is present at higher levels in the lungs than in the brain. Researchers want to see if a drug called \[11C\]ER176 can provide an image of this protein in the brain. Objective: \- To test the a...
What is the current status of trial NCT02147392?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 16 participants. The study started on 2014-05-14. Estimated completion is 2016-06-16.
What interventions are being tested in trial NCT02147392?
The interventions under investigation include: [11C]ER-176 (DRUG).
Who is sponsoring clinical trial NCT02147392?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.